GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering […]
– Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. – Conducted first stakeholder assessment […]